OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
October 03, 2021
Conventional and robotic automation inside closed systems reduces risk.
Evolving equipment designs meet the unique needs of continuous processing techniques.
September 29, 2021
Alternatives to animal testing and in-vivo assays are occurring as a result of recent scientific advances.
September 23, 2021
In an amendment to their existing contract manufacturing agreement, Celsian and Poly Pharm expand GEN-1 program collaboration to add clinical and commercial batches of investigational vaccine.
New data finds J&J COVID-19 vaccine and booster to provide increased protection against COVID-19.
September 16, 2021
Considering interactions and understanding regulatory requirements are crucial when developing a drug or biologic product for use with a medical device.
September 13, 2021
When designing and manufacturing a pMDI or DPI combination drug-delivery device, the commercial stage should be kept in mind from the beginning of development.
September 03, 2021
The intranasal route of administration is showing clinical promise, particularly for COVID-19, but there are multiple hurdles to overcome to ensure successful formulation.
The potential for okra gum as a polymer candidate for new oral drug formulations was evaluated.
August 31, 2021
It is important to use correct organization and appropriate methods for demonstrating biosimilar comparability to support regulatory filings.